Multiple Myeloma: Isatuximab and Lenalidomide Study

We are comparing two treatment plans for newly diagnosed low-risk multiple myeloma patients to see which is more effective in reducing cancer cells. This study aims to understand the best approach for long-term patient health.

>2 years Efficacy phase (II)No Placebo Partially Remote Standard Medicines Oral InjectionHematologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Bortezomib Eg

Bortezomib Eg is a cancer medicine used to treat multiple myeloma and certain types of lymphoma.

Lenalidomide

Lenalidomide is a medicine used to treat certain blood cancers and bone marrow disorders, including multiple myeloma.

Sarclisa

Sarclisa is a medicine used to treat multiple myeloma, a type of blood cancer.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Betamethasone Sodium Phosphate Ph. Eur

Betamethasone sodium phosphate is a substance that reduces inflammation and calms the immune system.

Bortezomib

Bortezomib is a substance that blocks cellular protein breakdown to treat certain blood cancers, including multiple myeloma.

Dexamethasone

Dexamethasone is a steroid that reduces inflammation and suppresses the immune system to treat allergic, inflammatory, and autoimmune conditions.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

7,5 Mg Stada

Abormib

Adabonib

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Klinikum Bielefeld gGmbH

Klinik für Onkologie, Hämatologie und Palliativmedizin

Bielefeld, Germany

Onkologie Donauwoerth (MVZ) GmbH

Onkologische Zentren Onkomedeor

Dachau, Germany

DONAUISAR Klinikum Deggendorf-Dingolfing-Landau gKU

Onkologie und Hämatologie

Deggendorf, Germany

Sponsor: University Medical Centre Schleswig-Holstein

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.